New alliance through partnership agreement
OPHTEC signs agreement with VSA for Argentinian marketplace.


Colin Kerr
Published: Tuesday, July 9, 2019
OPHTEC BV has signed a partnership agreement with VSA to commercialise Ophtec’s products in the Argentinian marketplace.
The Precizon™ IOL line as well as the Artisan® and Artiflex® line of Iris-Fixated Intraocular lenses are some of the products that will be commercialised by VSA.
Teresa Filhó, Ophtec’s Export Manager, said: “Ophtec has a passion for vision and we look forward to continuing serving the Argentinian market and introducing our cataract lenses Precizon™.”
Mauro Alvarez, sales director at VSA, noted: “I am proud to introduce this new alliance between VSA Alta Complejidad and Ophtec in Argentina:
“It is undoubtedly a great opportunity to start working with such a prestigious company as Ophtec, which over its 35 years has remained faithful to his own ideas, always developing avant-garde concepts and products for the most demanding ophthalmologists.”
https://www.ophtec.com/
Tags: partnership
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.